Skip to content
DataLookout
Menu

NCT06337552

High-Fermented Food Intervention Among Locally Advanced Rectal Cancer Patients (The FEED Trial)

StatusActive, Not Recruiting
PhaseNot applicable
Primary completion
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 10 versions: 5 with changes below, 5 re-verified with no change. See every version on ClinicalTrials.gov ↗

  1. Minor Primary completion date changed from estimate of Mar 2027 to Jul 2, 2026
    • Study completion date: Mar 2027 to Jan 2027
    • Eligibility criteria expanded, about 21 words
  2. Minor Trial status changed: Recruiting → Active, Not Recruiting
    • Enrollment reduced: 54 → 39 participants
    • Site details revised
    v9
  3. Notable Enrollment target: 30 to 54
    • Primary endpoints: 6 to 7
    • Eligibility criteria expanded, about 55 words
    • Site contact updated
    v3
  4. Notable Start date: Feb 19, 2024 to Apr 4, 2024v2
  5. Study First Submitted
  • Notable: the plan changed
  • Minor: routine updates

Endpoints

Primary

Effects of the FEED-FF diet on clinical response to chemoradiation (Rectal Cancer Patients)
Timeframe: At Baseline and Up to 12.5 Weeks
Effects of the FEED-FF diet on clinical response to immunotherapy (Lung Cancer Patients)
Timeframe: At Baseline and Up to 12.5 Weeks
Effects of FEED-FF diet on the gut microbiome
Timeframe: At Baseline, Week 6.5 and Up to 12.5 Weeks
Effects of FEED-FF diet on local immune-related biomarkers
Timeframe: At Baseline and Up to 12.5 Weeks
Effects of FEED-FF diet on quality of life
Timeframe: At Baseline, Week 6.5 and Up to 12.5 Weeks
Efficacy of the FEED-FF intervention
Timeframe: At Baseline, Week 6.5 and Up to 12.5 Weeks
Feasibility of the FEED-FF intervention
Timeframe: At Baseline, Week 6.5 and Up to 12.5 Weeks

Arms and interventions

FEED-FFExperimental

Participants will be asked to pick up the fermented foods at the Research Kitchen at Moffitt. Participants will be asked to eat 3-6 servings of FFs per day, from 1 week prior to treatment start through 12 weeks after treatment start/until the restaging scope is completed. At baseline, the end of week 6.5 and again at week 12.5, participants will be asked to provide biospecimens including a stool sample collected at home and a blood specimen collected in clinic. Participants will be asked to complete a food frequency questionnaire, a quality-of-life survey, two symptom related surveys, and a stool collection questionnaire at these same timepoints. After the dietary intervention, participants will be asked to complete an exit survey to provide feedback on the study and intervention.

Standard of Care (SUC)Active comparator

Participants will receive general healthy eating handouts similar to current usual care documents provided in clinic. These handouts will detail typical healthy foods and the suggested level of intake, or servings per day. At baseline, the end of week 6.5 and again at week 12.5, participants will be asked to provide biospecimens including a stool sample collected at home and a blood specimen collected in clinic. Participants will be asked to complete a food frequency questionnaire, a quality-of-life survey, two symptom related surveys, and a stool collection questionnaire at these same timepoints.

Other: FEED-FF, Standard of Care (SUC)

Sites

1 site in 1 country

  • Moffitt Cancer CenterTampa, Florida, United States